Author

S. Giordano

Institutions: Boston Medical Center, Dana-Farber Cancer Institute, Candiolo Cancer Institute

Observed institutions: Boston Medical Center, Dana-Farber Cancer Institute, Candiolo Cancer Institute

OpenAlex ID: A5126237309

Abstract PS3-11-04: Adjuvant Ado-Trastuzumab Emtansine (T-DM1) for Older Patients with HER2+ Breast Cancer - Results from the ATOP Study

2026 · R. A. Freedman, H. Heiling, et al. · Clinical Cancer Research · 1

646eP Epstein–Barr virus drives tolerance to targeted inhibition in gastric cancer

2026 · S. Gramolelli, L. Cutrone, et al. · Annals of Oncology

Works count: 2

Citation count: 1

H-index: 1

I10-index: